Ricevi le ultime notizie sulle azioni Compass Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di CMPX

Ultime notizie per

COMPASS THERAPEUTICS INC

Compass Therapeutics

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics Inc

Earnings

Press Releases

Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update

Biotech

News

General

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference

Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025

Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update

IPOs

Compass Therapeutics Announces Proposed Public Offering

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

Compass Therapeutics to Participate in Upcoming September Investor Events

Compass Therapeutics to Participate in Upcoming November Investor Events

Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

CMPX

Absci

ADC Therapeutics

Akebia Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Emergent BioSolutions

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Gossamer Bio

Inventiva S.A. - American Depository Shares

Inventiva

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharmaceuticals

Keros Therapeutics

Lexeo Therapeutics

Monopar Therapeutics

Myriad Genetics

NovaBridge Biosciences - American Depositary Shares

NovaBridge Biosciences

Neurogene

Ocugen

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Organogenesis Holdings

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Regenxbio

Rigel Pharmaceuticals, Inc. - Common Stock

Comments

Compass Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO